Korean Circ J.  2007 May;37(5):187-190. 10.4070/kcj.2007.37.5.187.

High Density Lipoprotein Cholesterol Comes of Age

Affiliations
  • 1Yonsei University Research Institute of Science for Aging, Seoul, Korea. lipidcho@yonsei.ac.kr

Abstract

Despite the excellent success of lowering low-density lipoprotein cholesterol (LDLc) cholesterol for treating coronary heart disease (CHD), a major part of the population still suffer from CHD. This fact is more prominent among the high risk patients who receive lipid lowering treatment with statins. This treatment is based on the prevailing view that LDL cholesterol (LDLc) is the only important risk factor for CHD. It is well known that HDL plays a crucial role for preventing CHD. Several epidemiologic studies and clinical trials have reported that high density lipoprotein cholesterol (HDLc) is an independent risk factor for CHD as well. A large scale meta-analysis of clinical trials clearly supports that increasing HDLc is equally important as decreasing LDLc, suggesting that physicians should pay attention to increasing HDLc as well as decreasing LDLc. Ongoing trials that are focused on this issue will test this hypothesis in the near future.

Keyword

LDL cholesterol; HDL cholesterol; Coronary heart disease

MeSH Terms

Cholesterol
Cholesterol, HDL*
Cholesterol, LDL
Coronary Disease
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lipoproteins
Risk Factors
Cholesterol
Cholesterol, HDL
Cholesterol, LDL
Lipoproteins
Full Text Links
  • KCJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr